Inflammatory Responses to Respiratory Syncytial Virus (RSV) Infection and the Development of Immunomodulatory Pharmacotherapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|10|1424-1431

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.10, 2012-04, pp. : 1424-1431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidemiological Aspects of Respiratory Syncytial Virus (RSV) Infections in Italy: a National Survey

By Alvaro G   Zuccotti GV  

The Journal of International Medical Research, Vol. 28, Iss. 5, 2000-09 ,pp. : 207-213

Field House Publishing

Access to resources Recommend Favorite

Development of respiratory syncytial virus vaccines

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Emerging drugs for respiratory syncytial virus infection

By Olszewska Wieslawa   Openshaw Peter  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite

Respiratory Syncytial Virus Infection in Elderly Adults

By Falsey Ann R.   Walsh Edward E.  

Drugs & Aging, Vol. 22, Iss. 7, 2005-01 ,pp. : 577-587

Adis International

Access to resources Recommend Favorite

Respiratory Syncytial Virus Infection in Adult Populations

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 2, 2012-04 ,pp. : 98-102

Bentham Science Publishers

Access to resources Recommend Favorite